Cited by 420Ovarian function and disordersSexual Differentiation and DisordersAdrenal Hormones and Disorders

Relative Prevalence of Different Androgen Excess Disorders in 950 Women Referred because of Clinical Hyperandrogenism

Carmina, E., Rosato, F., Jannì, A., Rizzo, M., Longo, R. A.·2006·The Journal of Clinical Endocrinology & Metabolism

Abstract

CONTEXT: We undertook this study to estimate the prevalence of the various androgen excess disorders using the new criteria suggested for the diagnosis of polycystic ovary syndrome (PCOS). SETTING: The study was performed at two endocrine departments at the University of Palermo (Palermo, Italy). PATIENTS: The records of all patients referred between 1980 and 2004 for evaluation of clinical hyperandrogenism were reevaluated. All past diagnoses were reviewed using the actual diagnostic criteria. To be included in this study, the records of the patients had to present the following available data: clinical evaluation of hyperandrogenism, body weight and height, testosterone (T), free T, dehydroepiandrosterone sulfate, 17-hydroxyprogesterone, progesterone, and pelvic sonography. A total of 1226 consecutive patients were seen during the study period, but only the scores of 950 patients satisfied all criteria and were reassessed for the diagnosis. RESULTS: The prevalence of androgen excess disorders was: PCOS, 72.1% (classic anovulatory patients, 56.6%; mild ovulatory patients, 15.5%), idiopathic hyperandrogenism, 15.8%; idiopathic hirsutism, 7.6%; 21-hydroxylase-deficient nonclassic adrenal hyperplasia, 4.3%; and androgen-secreting tumors, 0.2%. Compared with other androgen excess disorders, patients with PCOS had increased body weight whereas nonclassic adrenal hyperplasia patients were younger and more hirsute and had higher serum levels of T, free T, and 17-hydroxyprogesterone. CONCLUSIONS: Classic PCOS is the most common androgen excess disorder. However, mild androgen excess disorders (ovulatory PCOS and idiopathic hyperandrogenism) are also common and, in an endocrine setting, include about 30% of patients with clinical hyperandrogenism.

Integrity signals

Registry

Crossref · 10.1210/jc.2005-1457

Cites

18 of 18 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • Hyperandrogenism can occur without cutaneous manifestations even though hirsutism is common among women with hyperandrogenism.

    “Even though hirsutism is common among women with hyperandrogenism, the latter can occur in the absence of cutaneous manifestations [2,3]”

Cites

Flagged first, then by citations

Cited by

Sorted by citations

Authors
Carmina, E., Rosato, F., Jannì, A., Rizzo, M., & Longo, R. A.
Affiliations
University of Palermo (IT)
Corresponding author
Carmina, E.
Venue
The Journal of Clinical Endocrinology & Metabolism
Published
2006-01
Volume
91
Issue
1
Pages
2-6
ISSN
  • 0021-972X (ISSN-L)
  • 1945-7197
OpenAlex
W2157699773
Cited by
420
References
18
Citations by year
2026: 8 · 2025: 15 · 2024: 15 · 2023: 19 · 2022: 21 · 2021: 16 · 2020: 14 · 2019: 29 · 2018: 13 · 2017: 17 · 2016: 25 · 2015: 29 · 2014: 26 · 2013: 20 · 2012: 27
FWCI
27.91
Type
journal article
Language
en
Open access
closed
Locations
  • The Journal of Clinical Endocrinology & Metabolism (publishedVersion)
  • PubMed (publishedVersion)
  • Nova Science Publishers (Nova Science Publishers, Inc.) (submittedVersion)
Topics
  • Health Sciences › Medicine › Reproductive Medicine › Ovarian function and disorders
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Sexual Differentiation and Disorders
  • Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Adrenal Hormones and Disorders
Keywords
polycystic ovary syndrome, idiopathic hirsutism, 21-hydroxylase deficiency, androgen-secreting tumor, prevalence, diagnostic criteria, testosterone, 17-hydroxyprogesterone, body weight
MeSH terms
Acne Vulgaris, Adolescent, Adult, Alopecia, Androgens, Anovulation, Body Height, Body Weight, Diagnosis, Differential, Female, Hirsutism, Humans, Neoplasms, Ovary, Pelvis, Polycystic Ovary Syndrome, Progesterone, Retrospective Studies, Testosterone, Ultrasonography, Body Mass Index, Hyperandrogenism, 17-alpha-Hydroxyprogesterone

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review